Current Report Filing (8-k)
27 7월 2016 - 5:32AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
D.C. 20549
______________
FORM 8-K
______________
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of
t
he
Securities Exchange Act of 1934
Date
of Report (Date of Earliest Event Reported):
July
26, 2016
USANA HEALTH
SCIENCES, INC.
(Exact
name of registrant as specified in its charter)
Utah
(State
or other jurisdiction of incorporation)
001-35024
|
|
87-0500306
|
(Commission File No.)
|
|
(IRS Employer Identification
|
|
|
Number)
|
3838 West Parkway Boulevard
Salt Lake City, Utah 84120
|
(Address
of principal executive offices,
Zip
Code)
|
Registrant’s
telephone number, including area code:
(801)
954-7100
|
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item 2.02 Results of Operations and Financial
Condition.
On July 26, 2016, USANA Health Sciences, Inc. issued a press release
announcing its financial results for the second quarter and six months
ended July 2, 2016. The release also announced that the Company will
post a document titled “Management Commentary, Results and Outlook” on
the Company’s website and that executives of the company would hold a
conference call with investors, to be broadcast over the World Wide Web
and by telephone and provided access information, date and time for the
conference call. The Company noted that the call will consist of brief
remarks by the Company’s management team, before moving directly into
questions and answers. A copy of the press release, and the Management
Commentary, Results and Outlook, are furnished herewith as Exhibits to
this Current Report on Form 8-K and are incorporated herein by
reference. These documents will be posted on the Company’s corporate
website, www.usanahealthsciences.com.
The information in this Current Report is being furnished and shall not
be deemed “filed” for the purposes of Section 18 of the Securities
Exchange Act of 1934, as amended, or otherwise subject to the
liabilities of that Section. The information in this Current Report
shall not be incorporated by reference into any registration statement
or other document pursuant to the Securities Act of 1933, as amended.
The furnishing of the information in this Current Report is not intended
to, and does not, constitute a representation that such furnishing is
required by Regulation FD or that the information this Current Report
contains is material investor information that is not otherwise publicly
available.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits
Exhibit 99.1 Press release issued by USANA Health Sciences, Inc.
dated July 26, 2016 (furnished herewith).
Exhibit
99.2 Management Commentary, Results and Outlook provided by USANA
Health Sciences, Inc. dated July 26, 2016 (furnished herewith).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC.
|
|
|
|
|
|
|
|
|
By:
/s/ Paul A. Jones
|
|
|
|
|
|
Paul A. Jones, Chief Financial Officer
|
|
|
|
Date:
|
July 26, 2016
|
|
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
USANA Health Sciences (NYSE:USNA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024